Literature DB >> 23292643

Prognostic significance of lymph node characteristics on survival in esophageal squamous cell carcinomas.

Ning Wu1, Zhiming Chen, Liewen Pang, Qinyun Ma, Gang Chen.   

Abstract

OBJECTIVES: To investigate the prognostic significance of lymph node characteristics (total number of resected lymph nodes, metastatic lymph node ratio, and metastatic lymph nodes site) on survival in patients with esophageal squamous cell carcinoma.
METHODS: Patients who underwent esophagectomy at Huashan Hospital, Fudan University, between October 1, 2003, and December 31, 2008, were reviewed. Survival data and clinicopathological characteristics were collected.
RESULTS: Among 205 patients, the median overall survival time was 48.0 months and the overall 5-year survival rate was 44.7 %. The independent risk factors for disease-free survival were the metastatic lymph node ratio (P < 0.001) and the number of positive lymph nodes (P < 0.001) and not the total number of resected lymph nodes (Χ (2) = 3.063, P = 0.216). There was no difference in survival between patients with extrathoracic and intrathoracic lymph node metastasis (Χ (2) = 0.295, P = 0.587). No significant relation was found between tumor location and the site of metastatic lymph nodes (rs = 0.125, P = 0.245).
CONCLUSIONS: Our finding revealed that the ratio and the number, but not the site, of metastatic lymph nodes were independent prognostic risk factors in esophageal squamous cell carcinomas. We suggest taking these factors into consideration for better estimation of prognosis.

Entities:  

Mesh:

Year:  2013        PMID: 23292643     DOI: 10.1007/s00508-012-0310-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  23 in total

1.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Authors:  Farin Kamangar; Graça M Dores; William F Anderson
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

2.  Significance of lymph node capsular invasion in esophageal squamous cell carcinoma.

Authors:  Makoto Sakai; Shigemasa Suzuki; Akihiko Sano; Naritaka Tanaka; Takanori Inose; Makoto Sohda; Masanobu Nakajima; Tatsuya Miyazaki; Hiroyuki Kuwano
Journal:  Ann Surg Oncol       Date:  2012-06       Impact factor: 5.344

3.  A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus.

Authors:  T Nishihira; K Hirayama; S Mori
Journal:  Am J Surg       Date:  1998-01       Impact factor: 2.565

4.  Does systematic 2-field lymphadenectomy for esophageal malignancy offer a survival advantage? Results from 178 consecutive patients.

Authors:  D J Martin; N G Church; C W Kennedy; G L Falk
Journal:  Dis Esophagus       Date:  2008-05-02       Impact factor: 3.429

5.  Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single-institution experience.

Authors:  Bin Li; Haiquan Chen; Jiaqing Xiang; Yawei Zhang; Chenguang Li; Haichuan Hu; Yang Zhang
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-11       Impact factor: 5.209

6.  Impact of lymph-node metastasis site in patients with thoracic esophageal cancer.

Authors:  Chikara Kunisaki; Hirochika Makino; Jun Kimura; Takashi Oshima; Shoichi Fujii; Ryo Takagawa; Takashi Kosaka; Hidetaka A Ono; Hirotoshi Akiyama
Journal:  J Surg Oncol       Date:  2010-01-01       Impact factor: 3.454

7.  Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma.

Authors:  Yoshifumi Baba; Masayuki Watanabe; Hironobu Shigaki; Shiro Iwagami; Takatsugu Ishimoto; Masaaki Iwatsuki; Hideo Baba
Journal:  Surgery       Date:  2012-09-12       Impact factor: 3.982

8.  The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer.

Authors:  Wen-Hu Hsu; Po-Kuei Hsu; Chih-Cheng Hsieh; Chien-Sheng Huang; Yu-Chung Wu
Journal:  J Gastrointest Surg       Date:  2009-08-12       Impact factor: 3.452

9.  Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.

Authors:  Alexander J Greenstein; Virginia R Litle; Scott J Swanson; Celia M Divino; Stuart Packer; Juan P Wisnivesky
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

10.  Prognostic significance of solitary lymph node metastasis in patients with squamous cell carcinoma of middle thoracic esophagus.

Authors:  Jie Wu; Qi-Xun Chen; Xing-Ming Zhou; Wei-Ming Mao; Mark J Krasna; Li-Song Teng
Journal:  World J Surg Oncol       Date:  2012-10-04       Impact factor: 2.754

View more
  9 in total

1.  Recurrent laryngeal nerve lymph node dissection may not be suitable for all early stage esophageal squamous cell carcinoma patients: an 8-year experience.

Authors:  Shaobin Yu; Jihong Lin; Chenshu Chen; Jiangbo Lin; Ziyang Han; Wenwei Lin; Mingqiang Kang
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  Fibroblast Activation Protein-α Expressing Fibroblasts Promote Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma.

Authors:  Feng Li; Xia Wu; Zhixiang Sun; Peng Cai; Ligao Wu; Duojie Li
Journal:  Onco Targets Ther       Date:  2020-08-14       Impact factor: 4.147

3.  Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma.

Authors:  Charles Lemarignier; Frédéric Di Fiore; Charline Marre; Sébastien Hapdey; Romain Modzelewski; Pierrick Gouel; Pierre Michel; Bernard Dubray; Pierre Vera
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-07-19       Impact factor: 9.236

4.  Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis.

Authors:  Yuming Zhao; Shengyi Zhong; Zhenhua Li; Xiaofeng Zhu; Feima Wu; Yanxing Li
Journal:  Oncotarget       Date:  2017-07-15

5.  The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.

Authors:  Ning Wu; Zunguo Du; Yongjun Zhu; Yang Song; Liewen Pang; Zhiming Chen
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

6.  Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment.

Authors:  Xu Li; Wenxiang Wang; Yong Zhou; Desong Yang; Jie Wu; Baihua Zhang; Zhining Wu; Jinming Tang
Journal:  World J Surg Oncol       Date:  2018-02-09       Impact factor: 2.754

7.  The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients.

Authors:  Jing Wen; Kong-Jia Luo; Qian-Wen Liu; Geng Wang; Mei-Fang Zhang; Xiu-Ying Xie; Hong Yang; Jian-Hua Fu; Yi Hu
Journal:  Oncotarget       Date:  2016-06-21

8.  The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell carcinoma.

Authors:  Ning Wu; Yingfeng Zhu; Xiao Xu; Yongjun Zhu; Yang Song; Liewen Pang; Zhiming Chen
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

9.  Prognostic significance of middle paraesophageal lymph node metastasis in resectable esophageal squamous cell carcinoma: A STROBE-compliant retrospective study.

Authors:  Huang Hong; Hou Jie; Rao Liyu; Chen Zerui; Shu Borong; Liang Hongwei
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.